Aspen Pharmacare Holdings Limited provided earnings guidance for the six months ended 31 December 2020. Revenue growth from continuing operations as reported, and in constant exchange rates is expected to be in the range of 16% to 18%. Earnings per share ­ Continuing operations to be in the range of 484.7 cents per share to 505.3 cents per share and total earnings per share to be in the range of 541.4 cents per share to 570.2 cents per share.